LIANHE TECHNOLOGY(SZ:002250)2022-12-08 02:06Group 1: Company Overview and Leadership - The new executive Andreas has joined the company to enhance its pharmaceutical and pharmaceutical intermediate business development [1][2] - The company has established strong partnerships with major international pharmaceutical companies, providing opportunities for growth [2][3] Group 2: Business Growth and Strategy - The company anticipates stable growth in its pesticide and pesticide intermediate business over the next 3 to 5 years [2][4] - The company is exploring mergers and acquisitions as part of its 2020 strategic plan, focusing on both pesticide and pharmaceutical sectors [2][3] Group 3: Service Offerings and Market Position - The company provides two types of services: customized product services and new service models, including R&D services [2][4] - The company positions itself as a leading CMO (Contract Manufacturing Organization) with a strong reputation in both domestic and international markets [4][5] Group 4: Market Dynamics and Challenges - The expiration of patents in the pharmaceutical industry is expected to have a significant price impact but limited quantity impact on the market [4][5] - The company is aware of the competitive landscape and aims to leverage its experience in pesticide production to enhance its pharmaceutical capabilities [4][5] Group 5: Environmental and Safety Investments - The company invested over 100 million in environmental protection in 2014, emphasizing the importance of sustainable development [5]